Recall D-0230-2026

US Class II Ongoing · initiated 2025-10-31

Recalling firm

Novocol Pharmaceutical of Canada, Inc.

Product

3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.

Reason for recall

Defective container: cracked/broken cartridges

← All recalls